The pharmaceutical gelatin market Growth was valued at USD 1.15 billion in 2022. It is projected to reach USD 1.76 billion by 2030, with a compound annual growth rate (CAGR) of 5.4% during the forecast period from 2023 to 2030.
This growth trajectory highlights the increasing demand and potential of the pharmaceutical gelatin market. With a steady CAGR, the market is expected to witness substantial expansion in the coming years.
Pharmaceutical gelatin, a vital ingredient in the pharmaceutical industry, plays a crucial role in the production of capsules, tablets, and other drug delivery systems. Its unique properties, such as excellent binding capabilities and compatibility with various active pharmaceutical ingredients (APIs), make it a preferred choice for pharmaceutical manufacturers.
The rising prevalence of chronic diseases, coupled with the growing geriatric population, is driving the demand for pharmaceutical gelatin. As the global population continues to age, the need for effective and convenient drug delivery systems is escalating. Pharmaceutical gelatin offers a reliable solution, ensuring the safe and efficient delivery of medications.
Furthermore, the increasing focus on research and development activities in the pharmaceutical sector is expected to fuel the market growth. Pharmaceutical companies are investing heavily in developing innovative drug formulations, which require high-quality gelatin for encapsulation purposes. This trend is anticipated to contribute significantly to the expansion of the pharmaceutical gelatin market.
Geographically, North America currently dominates the market, owing to the presence of major pharmaceutical companies and a well-established healthcare infrastructure. However, Asia Pacific is projected to witness substantial growth during the forecast period. The region's expanding pharmaceutical industry, coupled with the rising healthcare expenditure and growing population, is creating lucrative opportunities for market players.
In conclusion, the pharmaceutical gelatin market is poised for significant growth in the coming years. With its indispensable role in drug delivery systems and increasing demand from the pharmaceutical industry, the market is expected to reach USD 1.76 billion by 2030
Get Sample Report @ https://www.snsinsider.com/sample-request/2242
Market Segmentation
By Application
- Hard Capsules
- Soft Capsules
- Tablets
Absorbable Hemostats
By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
By Function
- Stabilizing agents
- Thickening agents
- Gelling agents & Other Functions
By Type
- Type A
- Type B
Key Players
Major key players are Capsugel, Gelita AGv, Catelent Inc., Rousselot, Sterling Gelatin, Norland Products Inc, Weishardt, Tessenderlo Group, Roxlor llc, Nitta Gelatin Inc, and other players.
Table of Contents
1.Introduction
2.Research Methodology
3.Market Dynamics
4.Impact Analysis
4.1COVID-19 Impact Analysis
4.2.Impact of Ukraine- Russia war
4.3.Impact of Ongoing Recession on Major Economies
5.Value Chain Analysis
6.Porter’s 5 Forces Model
7.PEST Analysis
8.Pharmaceutical Gelatin Market Segmentation, By Application
9.Pharmaceutical Gelatin Market Segmentation, By Source
10.Pharmaceutical Gelatin Market Segmentation, By Function
11.Pharmaceutical Gelatin Market Segmentation, By type
12.Regional Analysis
Other Trending Report
Mesenchymal Stem Cells Market Analysis
Forensic Technology Market Analysis
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com